(a) Diabetic Complications. Complications of diabetes remain a major area needing improvement [4, 5] . J. Lowe et al. in their paper entitled "The Guyana Diabetes and Foot Care Project: Improved Diabetic Foot Evaluation Reduces Amputation Rates by Two-Thirds in a Lower Middle Income Country" reported an overall 68% reduction in major amputations after initiation of a multi-expert intervention programme in Guyana: below-knee amputations were reduced by 80%, while above-knee amputations remained unchanged. These results are very encouraging.
Two papers "Vascular Effects of Dietary Advanced Glycation End Products" by A. Stirban and D. Tschöpe and "Diabetes, Endothelial Dysfunction, and Vascular Repair: What Should a Diabetologist Keep His Eye on?" by V. Altabas shed more light on diabetes-induced vascular injury and the underlying mechanisms, including the effect of advanced glycation end products (AGEs) [6] , depletion of nitric oxide (NO), and endothelial apoptosis.
Diabetic kidney function and diabetic nephropathy have been the object of some articles in this special issue. In their work titled "Inverse Levels of Adiponectin in Type 1 and Type 2 Diabetes Are in Accordance with the State of Albuminuria, " S. Ljubic et al. found that adiponectin increased in type 1 (T1DM) but decreased in type 2 diabetes (T2DM) with deterioration of albuminuria. These interesting results enrich our knowledge on the role of adiponectin as a risk marker of vascular disease in diabetes [7] , while the difference between the two diabetes types calls for additional investigation. In 19 patients with diabetic nephropathy receiving angiotensin converting enzyme inhibitors or angiotensin II receptor blockers, S. M. Lee et al. evaluated the effect of omega-3 fatty acids (3 g per day) versus olive oil on proteinuria in their study entitled "Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy. " Neither treatment succeeded in reducing proteinuria, possibly due to concomitant angiotensin converting enzyme inhibitor/angiotensin II receptor blocker treatment and to the absence of very severe proteinuria at baseline.
Including 150 patients with mild-to-moderate diabetic nephropathy, A. P. Silva et al. in their paper entitled 2 International Journal of Endocrinology "Low Magnesium Levels and FGF-23 Dysregulation Predict Mitral Valve Calcification as well as Intima Media Thickness in Predialysis Diabetic Patients" found that reduced magnesium and high levels of fibroblast growth factor-23 were independent predictors of mitral valve calcification and of increased carotid intima media thickness. These findings are a valuable contribution to the search for risk markers of vascular calcification in chronic kidney disease [8] . "The Blocking on the Cathepsin B and Fibronectin Accumulation in Kidney Glomeruli of Diabetic Rats" is a study by A. Wyczalkowska-Tomasik et al., who compared enalapril, losartan, enalapril plus losartan, spironolactone, and no treatment in terms of the activity of cathepsin B accumulation in the glomeruli. Enalapril plus losartan treatment increased glomerular activity of cathepsin B compared to untreated diabetic rats. Spironolactone increased this activity as well. These results need to be seen in the context of reninangiotensin-aldosterone system inhibition as a therapeutic strategy for diabetic nephropathy, but caution is needed when extrapolating to humans.
Other groups dealt with coronary artery disease (CAD) and cardiac structure. and CAD, along with increased insulin resistance, suggesting that these perturbations may be of relevance for the accelerated atherosclerosis in such patients. In their paper titled "The Difference Quantity of Urinary Peptides between Two Groups of Type 2 Diabetic Patients with or without Coronary Artery Disease, " G. Fu et al. examined T2DM patients and noted significant differences in the expression of peptides (fragments of isoform 1 of fibrinogen alpha chain precursor, prothrombin precursor, and inter-alpha-trypsin inhibitor heavy chain H4) between those with CAD and those without CAD, suggesting that we need to consider how such differences may be practically utilised in the search for CAD biomarkers. Similarly, E. C. Pereira et al. in their article entitled "Predictive Potential of Twenty-Two Biochemical Biomarkers for Coronary Artery Disease in Type 2 Diabetes Mellitus" found that 8 biomarkers (methionine, nitrate plus nitrite, n-acetyl--glucosaminidase, BMI, LDL, HDL, reduced glutathione, and L-arginine/asymmetric dimethyl-L-arginine) were associated with CAD in T2DM. Finally, K. Ziros et al. in their experimental study entitled "The effect of a low glycemic index diet on cardiac structure in an experimental model of diabetic rats" examined streptozotocininduced diabetic rats and found greater area, perimeter and length of collagen fibres in heart vessels among those under normal glycaemic index diet as compared with those under low glycaemic index diet, indicating the importance of the glycaemic index of experimental diets in the study of complications in experimental works. The HERCULES Study"'). Of note, the largest part of total expenditure (48%) was for management of comorbidities, while pharmaceutical treatment comprised 35.9% and antidiabetic treatment only 14.9%. The highest cost was seen in obese men with a long diabetes duration and those with poor education. These useful results have obvious implications in the face of Greek economic crisis and its impact on the treatment of diabetic complications [10] .
In their article entitled "Sitagliptin: Is It Effective in Routine Clinical Practice?" R. M. Dallumal et al. collected data from medical records of 457 T2DM patients. In the majority of these, sitagliptin was added to other antidiabetic agents, commonly metformin and/or sulfonylurea. The authors documented a −0.8% reduction in glycated haemoglobin within the first 6 months of sitagliptin treatment. However, no further improvement was seen during the next 6 treatment months. These observations are useful, but inhibitors of dipeptidyl peptidase 4 (DPP-4) usually maintain their efficacy longer [1] , and so the authors need to look at longer follow-up data. Results from a Community-Based Epidemiologic Survey" reported that the association between waist circumference and insulin resistance was independent of socioeconomic status, but its association with prediabetes was only significant in the highest socioeconomic level. These observations are interesting in terms of the interplay between societal and metabolic factors [11] and need further exploration. R. Diabetes" found that thyroxin-treated autoimmune thyroid disease (but not coeliac disease) was associated with reduced quality of life in children with T1DM. These findings increase our insight into the intricate psychological issues needing careful consideration in the modern management of T1DM [12] .
In the Norwegian study "The Chromosome 9p21 CVDand T2D-Associated Regions in a Norwegian Population (The documented that the use of a pedometer and a nutrition programme was successful in achieving both weight loss and increased physical activity over a 3-month period in women with prior gestational diabetes mellitus, cherishing the hope that this approach might contribute to the prevention of T2DM in later life.
